Savant Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,285
Closed -$263K 291
2017
Q3
$263K Buy
1,285
+55
+4% +$12.8K 0.06% 229
2017
Q2
$299K Sell
1,230
-60
-5% -$14.1K 0.07% 204
2017
Q1
$308K Buy
1,290
+320
+33% +$74.5K 0.08% 196
2016
Q4
$204K Buy
970
+40
+4% +$8.29K 0.05% 249
2016
Q3
$214K Sell
930
-548
-37% -$134K 0.06% 232
2016
Q2
$341K Sell
1,478
-257
-15% -$59.3K 0.1% 165
2016
Q1
$465K Buy
+1,735
New +$497K 0.14% 118

Other funds holding AGN

Savant Capital's AGN Position: Q4 2017 in Review

Savant Capital sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,285 shares — an estimated $263K sold.

Savant Capital first reported a position in AGN in Q1 2016 and held it in 7 quarters. The position peaked at $465K in Q1 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Savant Capital reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Savant Capital sold 1,285 Allergan plc shares in Q4 2017, an estimated $263K.
  • Savant Capital first reported a position in Allergan plc in Q1 2016 and held it in 7 quarters.
  • Savant Capital's Allergan plc position peaked at $465K in Q1 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Savant Capital's 13F filing for Q4 2017, filed 31 Jan 2018.